MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 98 filers reported holding MAGENTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $38,000 | -46.5% | 12,952 | -19.5% | 0.00% | – |
| Q4 2021 | $71,000 | -39.3% | 16,080 | 0.0% | 0.00% | – |
| Q3 2021 | $117,000 | -71.0% | 16,080 | -61.1% | 0.00% | -100.0% |
| Q2 2021 | $404,000 | +8.9% | 41,314 | +31.9% | 0.00% | – |
| Q1 2021 | $371,000 | +50.8% | 31,328 | 0.0% | 0.00% | – |
| Q4 2020 | $246,000 | +15.5% | 31,328 | 0.0% | 0.00% | – |
| Q3 2020 | $213,000 | +10.9% | 31,328 | +22.7% | 0.00% | – |
| Q2 2020 | $192,000 | +1.1% | 25,540 | -15.8% | 0.00% | – |
| Q1 2020 | $190,000 | -58.2% | 30,324 | +1.1% | 0.00% | -100.0% |
| Q4 2019 | $455,000 | +47.7% | 29,982 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $308,000 | -30.3% | 29,982 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $442,000 | +20.1% | 29,982 | +34.3% | 0.00% | 0.0% |
| Q1 2019 | $368,000 | +951.4% | 22,325 | +265.9% | 0.00% | – |
| Q4 2018 | $35,000 | -52.1% | 6,102 | 0.0% | 0.00% | – |
| Q3 2018 | $73,000 | – | 6,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 6,758,204 | $19,599,000 | 7.18% |
| TCG Crossover Management, LLC | 2,124,122 | $6,160,000 | 2.47% |
| Atlas Venture Life Science Advisors, LLC | 3,476,536 | $10,082,000 | 1.28% |
| Deep Track Capital, LP | 5,359,000 | $15,541,000 | 1.00% |
| GREAT POINT PARTNERS LLC | 1,170,000 | $3,393,000 | 0.82% |
| Casdin Capital, LLC | 2,773,468 | $8,043,000 | 0.36% |
| Alphabet Inc. | 3,339,138 | $9,684,000 | 0.31% |
| Bleichroeder LP | 484,400 | $1,405,000 | 0.25% |
| HARBOR CAPITAL ADVISORS, INC. | 151,599 | $440,000 | 0.21% |
| Integral Health Asset Management, LLC | 201,000 | $583,000 | 0.15% |